Tag: Spinal Cord Injury Research
Craig H. Neilsen Foundation supports studies addressing the environmental barriers, chronic pain and racial disparities that affect individuals with spinal cord injury
EAST HANOVER, NJ. February 5, 2021. Kessler Foundation scientists received three spinal cord injury research grants from the Craig H. Neilsen Foundation to ensure that researchers have the capacity to complete projects delayed by the pandemic. The grants, which total nearly $113,000, were awarded to Amanda Botticello, PhD, MPH, Denise Fyffe, PhD, and Jeanne Zanca, PhD, MPT, who conduct research in the Center for Spinal Cord Injury Research and the Center for Outcomes and Assessment Research.
One of the reasons people rarely recover from spinal cord injury is the scar tissue that develops, preventing nerve cells from reconnecting. But a new study from Zhigang He, PhD, of the F.M. Kirby Neurobiology Center at Boston Children’s Hospital, demonstrated a way to minimize scar cell formation in adult mice after a spinal cord injury. The study, published in Nature, offers insights for new approaches to treating spinal cord injuries.
Dynamic networks that specialize in the transmission of information generally consist of multiple components, including not only primary processors, like computers, for example, but also numerous support applications and services. The human nervous system is fundamentally very similar—neurons, like computers, process and transmit information, sending molecular signals through axons to other neurons, all of which are supported by non-neuronal components, including an array of cells known as glia.
(NAPSI)—If you or someone you care about is ever among the approximately 17,700 Americans who each year, according to The Journal of American Medical Association, suffer a new spinal cord injury or the hundreds of thousands that continue to live with a spinal cord injury, you may be relieved to learn about recent research.
A team of researchers from University of Toronto Engineering and the University of Michigan has redesigned and enhanced a natural enzyme that shows promise in promoting the regrowth of nerve tissue following injury.
Their new version is more stable than the protein that occurs in nature, and could lead to new treatments for reversing nerve damage caused by traumatic injury or stroke.
National Institutes of Health grant will enable Hedong Li to focus on role of micorRNAs in the reprogramming process
UNIVERSITY PARK, Pa. — Hedong Li, associate research professor of biology, has been awarded $1.8 million from the National Institutes of Health (NIH) to study how microRNAs — small segments of genetic material — could be used in treatments for spinal cord injury. The five-year grant builds upon previous work by Li and colleagues to convert glial cells, support cells that surround neurons, into functioning neurons.
Two top scientists at the University of Virginia School of Medicine are seeking answers to questions about spinal cord injuries that have long frustrated the development of effective treatments.
The scientists, Jonathan Kipnis, PhD, and Kodi Ravichandran, PhD, are teaming up to understand why critical nerve cells called neurons continue to die after spinal cord injuries. So little is known that doctors aren’t even certain if the body’s immune response is beneficial or harmful.
In experiments on rats with spinal cord injuries, the rodents improved their walking ability following treatment.
Researchers have demonstrated a novel method that might regrow nerve cells at the site of spinal injuries.
Recently researchers discovered an axon guidance protein known as Plexin B2 in the central nervous system (CNS). During the spinal cord injury, this protein plays a significant role in the healing of the wound and neural repair.
The experiment was designed and conducted by the Icahn School of Medicine at Mount Sinai. This study could help the development of the treatments or therapies which target axon guidance pathways for treating the patients of Spinal cord injury more effectively.